Epic as an Effective, Low Toxicity Salvage Therapy for Patients with Poor Risk Lymphoma Prior to Beam High Dose Chemotherapy and Peripheral Blood Progenitor Cell Transplantation

1999 ◽  
Vol 35 (3-4) ◽  
pp. 339-345 ◽  
Author(s):  
N. C. McBride ◽  
M. C. Ward ◽  
M. J. Mills ◽  
A. G. Eden ◽  
A. Hughes ◽  
...  
2005 ◽  
Vol 91 (3) ◽  
pp. 237-240 ◽  
Author(s):  
Alfredo Tartarone ◽  
Jenna Wunder ◽  
Gianpiero Romano ◽  
Raffaele Ardito ◽  
Giovanni lodice ◽  
...  

High-dose chemotherapy followed by autologous bone marrow or peripheral blood progenitor cell transplantation represents a recognized option in the treatment of solid tumors and hematologic diseases. Patients receiving high-dose chemotherapy are traditionally supported with parenteral nutrition with the aim to prevent malnutrition secondary to gastrointestinal toxicity and metabolic alterations induced by the conditioning regimens. Nevertheless, well-defined guidelines for its use in this clinical setting are lacking and there are several areas of controversy.


1994 ◽  
Vol 5 (9) ◽  
pp. 795-802 ◽  
Author(s):  
E. van der Wall ◽  
D.J. Richel ◽  
M.J. Holtkamp ◽  
I.C.M. Slaper-Cortenbach ◽  
C.E. van der Schoot ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document